Article List

WPRIM Management System> DCMS> Journal of Korean Breast Cancer Society> > 4

Volume: 4

1. Immediate Free TRAM Flap Reconstruction after Mastectomy in Breast Cancer Patients.	Page:93—97
2. The Clinical Significance and Prognosis of Korean Young Age (younger or 35 year old) onset Breast Cancer.	Page:74—79
3. The Impact of Patient Age upon Locoregional and Systemic Failures after Breast Conservation Therapy: Comparison of the Results from the Groups above and below 35 Years.	Page:68—73
4. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer.	Page:161—166
5. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer.	Page:161—166
6. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy.	Page:128—135
7. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy.	Page:128—135
8. The Significance of Cytokeratin-20 Detection in Peripheral Blood and Bone Marrow of Breast Cancer Patients.	Page:185—191
9. Apoptosis Related Protein Expressions in Immunohistochemical Staining Using Tissue Microarrays of Breast Cancer.	Page:179—184
10. Relationship between Cathepsin D Expression and Other Prognostic Factors in Primary Breast Cancer.	Page:172—178
11. Use of the Triple Test for the Patients with Palpable Breast Masses.	Page:31—36
12. The Antiproliferating Effect of Diallyl Disulfide from Garlic on the Human Breast Cancer Cell Line (MCF-7).	Page:20—30
13. Significance on the Expression of Cyclin, MIB-1 in Benign and Malignant Papillary Lesion of the Breast.	Page:12—19
14. Loss of Expression of the PTEN Gene Product in the Infiltrating Ductal Carcinoma of the Breast and Its Relationship with Clinicopathologic Factors.	Page:6—11
15. Prognosis of GLUT1 Expression in Human Breast Carcinoma.	Page:167—171
16. The Relationship between Plasminogen Acti- vator Inhibitor-1 and Bone Marrow Microme- tastases in Breast Cancer.	Page:192—197
17. A Pychosocial Support Program for Women with Primary Breast Carcinoma.	Page:99—105
18. A Pychosocial Support Program for Women with Primary Breast Carcinoma.	Page:99—105
19. Causes and Sexual Hormonal Changes in Patients with Gynecomastia.	Page:106—110
20. Causes and Sexual Hormonal Changes in Patients with Gynecomastia.	Page:106—110
21. Reduction Surgery for Giant Breast.	Page:111—114
22. Reduction Surgery for Giant Breast.	Page:111—114
23. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer.	Page:115—119
24. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer.	Page:115—119
25. Micrometastasis of Sentinel Lymph Node in Breast Cancer.	Page:120—127
26. Micrometastasis of Sentinel Lymph Node in Breast Cancer.	Page:120—127
27. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer.	Page:136—143
28. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer.	Page:136—143
29. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast.	Page:144—151
30. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast.	Page:144—151
31. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer.	Page:152—160
32. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer.	Page:152—160
33. A Study on Modified Triple Test for Palpable Breast Mass.	Page:37—42
34. Clinical Analysis of Breast Cancer Surgeries in Korea.	Page:43—49
35. Clinical Analysis of Stage I and II Breast Cancer.	Page:50—56
36. Paget's Disease of the Breast.	Page:57—62
37. Breast Cancer in Third Decade-Does It Really Have a Poor Prognosis?.	Page:63—67
38. Clinical Significance of Rotter's Nodes in Patients with Breast Carcinomas.	Page:80—86
39. Combined Peritumoral and Subareolar Injection of Blue Dye Improves Sentinel Lymph Node Localization Rates.	Page:87—92
40. The Expression of High Mobility Group I (Y) Proteins in Human Breast Cancer.	Page:1—5